Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
3.
Eur J Cancer ; 117: 32-40, 2019 08.
Article in English | MEDLINE | ID: mdl-31229947

ABSTRACT

BACKGROUND: High incidence rates of keratinocyte carcinoma (KC) in Western countries put pressure on healthcare systems. The aim of this study was to describe clinical practice in order to identify areas for improvement. METHODS: A random selection of patients from the Integrated Primary Care Information database who consulted their general practitioner (GP) for suspicious or confirmed KC (n = 1597) was made in the analysis. For secondary care, 1569 patients with histologically confirmed KC were randomly selected from the Netherlands Cancer Registry. All patients were diagnosed between 2009 and 2013 and followed up until 2016. Details on diagnosis, treatment and care during follow-up were described. RESULTS: Among 942 patients who consulted their GP, KC was included in the working or differential diagnosis, but two-thirds (629) were not KC. If the GP suspected KC, the GP directly referred to a medical specialist in most cases (548 of 942). In half (470 of 967) of all confirmed KCs, a skin malignancy was not described in the initial working or differential diagnosis of the GP. The medical specialist treated the first primary KC in 86% (1369 of 1596) by excision, 4% (69 of 1596) by Mohs surgery and 10% (158 of 1596) by another treatment. Although follow-up is not recommended for low-risk basal cell carcinoma, 83% (29 of 35) received follow-up care. In contrast, 82% (60 of 73) patients with squamous cell carcinoma received less follow-up than recommended. CONCLUSIONS: Strengthening the diagnostic pathway for KC in primary care and reduction of low-value follow-up visits in secondary care seem potential areas for improving the efficiency of KC care.


Subject(s)
Delivery of Health Care/standards , General Practitioners/standards , Keratinocytes/pathology , Practice Patterns, Physicians'/standards , Quality Improvement , Skin Neoplasms/therapy , Specialization/standards , Aged , Carcinoma, Basal Cell/diagnosis , Carcinoma, Basal Cell/epidemiology , Carcinoma, Basal Cell/therapy , Carcinoma, Squamous Cell/diagnosis , Carcinoma, Squamous Cell/epidemiology , Carcinoma, Squamous Cell/therapy , Cohort Studies , Female , Follow-Up Studies , Humans , Male , Netherlands/epidemiology , Prognosis , Skin Neoplasms/diagnosis , Skin Neoplasms/epidemiology
4.
Br J Dermatol ; 181(1): 96-104, 2019 07.
Article in English | MEDLINE | ID: mdl-30801664

ABSTRACT

BACKGROUND: The increasing incidence of actinic keratosis (AK) is causing a large burden on healthcare systems. The current management of patients with AK seems to vary within and between primary and secondary care; however, an in-depth understanding of healthcare providers' management of AK is currently lacking. OBJECTIVES: To gain insight into the management of AK by exploring the underlying motives of current practices among general practitioners (GPs) and dermatologists in the Netherlands. METHODS: A qualitative study was conducted consisting of semistructured individual interviews with 22 GPs and 18 dermatologists focusing on the underlying motives regarding AK management. A predefined topic list was used. All interviews were audiotaped, transcribed verbatim and inductively analysed by two researchers drawing on elements of grounded theory. RESULTS: GPs reported conducting limited proactive clinical assessments of cutaneous photodamage due to a perceived lack of value, varying in their method of diagnosing AK. They mainly applied cryotherapy or referred to secondary care due to lack of experience, varying in their applications and providing mostly patient-driven follow-up care. They also reported a great need for guidelines due to a lack of knowledge of AK management. Dermatologists indicated pursuing proactive clinical assessments of cutaneous photodamage and the goal of providing guideline-driven AK care. However, patient preferences still largely influence both treatment choices and follow-up regimens. Furthermore, dermatologists reported the need to improve AK and skin cancer management in primary care. CONCLUSIONS: For AK care to become more standardized and uniform in Dutch primary care, the implementation of guidelines and (continuing) education are needed to address the commonly reported barriers of lack of value, experience and knowledge among GPs. For efficient use of care among dermatologists, shared decision-making tools along with adequate (framing of) patient information may be useful.


Subject(s)
Dermatology/methods , Keratosis, Actinic/therapy , Practice Patterns, Physicians'/statistics & numerical data , Primary Health Care/methods , Skin Neoplasms/prevention & control , Adult , Clinical Decision-Making/methods , Decision Making, Shared , Dermatologists/statistics & numerical data , Dermatology/education , Dermatology/standards , Dermatology/statistics & numerical data , Education, Medical, Continuing , Female , General Practitioners/statistics & numerical data , Humans , Keratosis, Actinic/etiology , Keratosis, Actinic/pathology , Male , Middle Aged , Netherlands , Physicians, Primary Care/education , Physicians, Primary Care/statistics & numerical data , Practice Guidelines as Topic , Practice Patterns, Physicians'/standards , Primary Health Care/standards , Primary Health Care/statistics & numerical data , Qualitative Research , Skin/pathology , Skin/radiation effects , Skin Neoplasms/etiology , Skin Neoplasms/pathology , Sunlight/adverse effects , Surveys and Questionnaires/statistics & numerical data
5.
Br J Dermatol ; 181(3): 544-553, 2019 09.
Article in English | MEDLINE | ID: mdl-30636037

ABSTRACT

BACKGROUND: The high prevalence of actinic keratosis (AK) requires the optimal use of healthcare resources. OBJECTIVES: To gain insight in to the healthcare utilization of people with AK in a population-based cohort, and the management of AK in a primary and secondary care setting. METHODS: A retrospective cohort study using three complementary data sources was conducted to describe the use of care, diagnosis, treatment and follow-up of patients with AK in the Netherlands. Data sources consisted of a population-based cohort study (Rotterdam Study), routine general practitioner (GP) records (Integrated Primary Care Information) and nationwide claims data (DRG Information System). RESULTS: In the population-based cohort (Rotterdam Study), 69% (918 of 1322) of participants diagnosed with AK during a skin-screening visit had no previous AK-related visit in their GP record. This proportion was 50% for participants with extensive AK (i.e. ≥ 10 AKs; n = 270). Cryotherapy was the most used AK treatment by both GPs (78%) and dermatologists (41-56%). Topical agents were the second most used treatment by dermatologists (13-21%) but were rarely applied in primary care (2%). During the first AK-related GP visit, 31% (171 of 554) were referred to a dermatologist, and the likelihood of being referred was comparable between low- and high-risk patients, which is inconsistent with the Dutch general practitioner guidelines for 'suspicious skin lesions' from 2017. Annually, 40 000 new claims representing 13% of all dermatology claims were labelled as cutaneous premalignancy. Extensive follow-up rates (56%) in secondary care were registered, while only 18% received a claim for a subsequent cutaneous malignancy in 5 years. CONCLUSIONS: AK management seems to diverge from guidelines in both primary and secondary care. Underutilization of field treatments, inappropriate treatments and high referral rates without proper risk stratification in primary care, combined with extensive follow-up in secondary care result in the inefficient use of healthcare resources and overburdening in secondary care. Efforts directed to better risk differentiation and guideline adherence may prove useful in increasing the efficiency in AK management. What's already known about this topic? The prevalence of actinic keratosis (AK) is high and, in particular, multiple AKs are a strong skin cancer predictor. The high prevalence of AK requires optimal use of healthcare resources. Nevertheless, (population based) AK healthcare utilization and management data are very rare. What does this study add? Although AK-related care already consumes substantial resources, about 70% of the AK population has never received care. Primary care AK management demonstrated underutilization of topical therapies and high referral rates without proper risk stratification, while in secondary care the extensive follow-up schedules were applied. This inefficient use of healthcare resources highlights the need for better harmonization and risk stratification to increase the efficiency of AK care.


Subject(s)
Keratosis, Actinic/therapy , Patient Acceptance of Health Care/statistics & numerical data , Practice Patterns, Physicians'/statistics & numerical data , Primary Health Care/statistics & numerical data , Secondary Care/statistics & numerical data , Administrative Claims, Healthcare/statistics & numerical data , Aftercare/statistics & numerical data , Aged , Aged, 80 and over , Cryotherapy/statistics & numerical data , Databases, Factual/statistics & numerical data , Dermatologic Agents/therapeutic use , Dermatologists/standards , Dermatologists/statistics & numerical data , Female , General Practitioners/standards , General Practitioners/statistics & numerical data , Guideline Adherence/statistics & numerical data , Humans , Keratosis, Actinic/diagnosis , Male , Middle Aged , Netherlands , Practice Guidelines as Topic , Practice Patterns, Physicians'/standards , Primary Health Care/standards , Referral and Consultation/standards , Referral and Consultation/statistics & numerical data , Retrospective Studies , Risk Assessment/standards , Risk Assessment/statistics & numerical data , Secondary Care/standards
6.
Br J Dermatol ; 180(6): 1420-1429, 2019 06.
Article in English | MEDLINE | ID: mdl-30597525

ABSTRACT

BACKGROUND: Providing follow-up to patients with low-risk basal cell carcinoma (BCC) can be considered as low-value care. However, dermatologists still provide substantial follow-up care to this patient group, for reasons not well understood. OBJECTIVES: To identify factors influencing current BCC follow-up practices among dermatologists and suggested strategies to de-adopt this low-value care. In addition, views of patients regarding follow-up care were explored. METHODS: A qualitative study was conducted consisting of 18 semistructured interviews with dermatologists and three focus groups with a total of 17 patients with low-risk BCC who had received dermatological care. The interviews focused on current follow-up practices, influencing factors and suggested strategies to de-adopt the follow-up care. The focus groups discussed preferred follow-up schedules and providers, as well as the content of follow-up. All (group) interviews were transcribed verbatim and analysed by two researchers using ATLAS.ti software. RESULTS: Factors influencing current follow-up care practices among dermatologists included complying with patients' preferences, lack of trust in general practitioners (GPs), financial incentives and force of habit. Patients reported varying needs regarding periodic follow-up visits, preferred to be seen by a dermatologist and indicated a need for improved information provision. Suggested strategies by dermatologists to de-adopt the low-value care encompassed educating patients with improved information, educating GPs to increase trust of dermatologists, realizing appropriate financial reimbursement and informing dermatologists about the low value of care. CONCLUSIONS: A mixture of factors appear to contribute to current follow-up practices after low-risk BCC. In order to de-adopt this low-value care, strategies should be aimed at dermatologists and GPs, and also patients.


Subject(s)
Aftercare/standards , Carcinoma, Basal Cell/therapy , Dermatology/standards , Medical Overuse/prevention & control , Skin Neoplasms/therapy , Adult , Aged , Attitude of Health Personnel , Dermatologists/standards , Female , Focus Groups , General Practitioners/standards , Humans , Male , Middle Aged , Patient Preference , Practice Guidelines as Topic , Practice Patterns, Physicians'/standards , Qualitative Research
7.
J Immunother Cancer ; 7(1): 14, 2019 01 18.
Article in English | MEDLINE | ID: mdl-30658697

ABSTRACT

Regulatory T cells (Tregs) may comprise different subsets allowing them to efficiently suppress different types of effector T cells. In this study, we show that high numbers of both conventional and Tbet co-expressing Foxp3hi Tregs accumulate in human papilloma virus (HPV)-driven oropharyngeal squamous cell carcinoma (OPSCC). The infiltration of Tbet+ Foxp3+ Tregs was strongly correlated with a concomitant tumor-specific and conventional type 1-oriented intratumoral T cell infiltrate. Both conventional CD4+CD25+CD127-Foxp3hi Tregs and their Tbethi counterparts exhibited an activated phenotype, co-expressed high levels of CTLA4 and Helios and exhibited a maximally demethylated Foxp3 gene locus TSDR, indicating their full capacity to impede a type 1 effector T cell response. Interestingly, while the prognostic value of conventional Tregs was neutral, a high intratumoral frequency of Tbet+ Tregs was associated with prolonged disease-specific survival, most likely because their presence reflected high numbers of effector T cells. The presence of these Tbet+ Tregs may in part explain why a dense type 1-oriented immune infiltrate in OPSCC is not enough to fully control tumor growth.


Subject(s)
Lymphocytes, Tumor-Infiltrating/immunology , Oropharyngeal Neoplasms/immunology , Papillomavirus Infections/immunology , T-Box Domain Proteins/immunology , T-Lymphocytes, Regulatory/immunology , Aged , Aged, 80 and over , Female , Forkhead Transcription Factors/immunology , Humans , Male , Middle Aged , Oropharyngeal Neoplasms/etiology , Papillomavirus Infections/complications , Uterine Cervical Neoplasms/etiology , Uterine Cervical Neoplasms/immunology
8.
Br J Dermatol ; 180(1): 122-129, 2019 01.
Article in English | MEDLINE | ID: mdl-29927480

ABSTRACT

BACKGROUND: Despite the high and rising incidence rate of keratinocyte cancer (KC) and the importance of incorporating patient values into evidence-based care, few studies have focused on the perspectives of patients with KC. OBJECTIVES: To identify the needs and preferences of patients with basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) regarding care. METHODS: A qualitative study was conducted consisting of three focus groups with patients with BCC and three focus groups with patients with SCC. In total 42 patients participated. In each focus group, the patients' needs and preferences regarding treatment and follow-up were discussed, using a predefined topic list. All sessions were transcribed verbatim and analysed by two researchers. RESULTS: The following needs and preferences were identified: (i) the need to receive all relevant, tailored information; (ii) a physician who takes you seriously and communicates well; (iii) a short waiting period and the best treatment with direct results; (iv) to be seen by the same physician; a preference for a dermatologist during (v) treatment and (vi) follow-up; (vii) a general need for structured follow-up care and (viii) a full-body skin examination during follow-up. Patients with BCC additionally expressed the need for openness and transparency and wanting to participate in shared decision making. CONCLUSIONS: It is advocated to organize skin cancer care that is better tailored to the needs of patients with KC, providing patient-centred care. This should include investing in the patient-physician relationship, and personalizing the type and form of information and the follow-up schedules. Adding the patient's perspective to current guidelines could facilitate this process.


Subject(s)
Carcinoma, Basal Cell/therapy , Carcinoma, Squamous Cell/therapy , Health Services Needs and Demand , Patient Preference , Skin Neoplasms/therapy , Aftercare/methods , Aftercare/organization & administration , Aged , Aged, 80 and over , Carcinoma, Basal Cell/diagnosis , Carcinoma, Squamous Cell/diagnosis , Decision Making , Dermatology/methods , Dermatology/organization & administration , Dermatology/standards , Evidence-Based Medicine/methods , Evidence-Based Medicine/organization & administration , Evidence-Based Medicine/standards , Female , Focus Groups , Humans , Male , Middle Aged , Netherlands , Patient Participation , Patient-Centered Care/methods , Patient-Centered Care/organization & administration , Patient-Centered Care/standards , Physician-Patient Relations , Practice Guidelines as Topic , Qualitative Research , Skin Neoplasms/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...